LUCENTIS® (ranibizumab injection) is an injection given in the eye in your retina specialist's office. Shortly after your injection, you will have a post-injection exam. Then you can go home. Bring a friend or family member with you so they can drive you home after you get your injection, as you may be sensitive to light for a while. This is because your eyes will have been dilated.
Prior to your injection, your eye will be cleaned to avoid an infection. Then your eye will be numbed. Once your eye has been numbed, you will feel a little pressure on your eye.
Injections were well tolerated in key clinical studies. In fact, nearly 95% of patients returned for their monthly injections.
After an injection:
- You may have some redness on the white part of your eye at the injection site
- You may see some specks in your vision
- Your retina specialist may give you antibiotic eye drops to use for a few days after the injection. He or she will tell you how to use them properly
- Ask your retina specialist if there are activities you should avoid
- Check your vision in both eyes using an Amsler grid and note any changes. Click here for an Amsler grid and instructions for use
Contact your retina specialist if your vision gets worse or the redness and specks don't go away after a few days.
Who is LUCENTIS for?
LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with wet age-related macular degeneration (AMD).
Important LUCENTIS Safety Information
Like any prescription medication, LUCENTIS is not for everyone. You should not use LUCENTIS if you have an infection in or around the eye.
Like other injections given into the eye, serious eye infection (endophthalmitis) and detached retina have occurred with LUCENTIS. Increases in eye pressure have been seen within 1 hour of an injection. Your eye doctor should monitor your eye pressure and eye health during the week after the injection. If your eye becomes red, sensitive to light, painful, or has a change in vision, you should seek immediate care from your eye doctor.
Although uncommon, conditions associated with eye- and non–eye-related blood clots (arterial thromboembolic events) may occur.
Serious side effects related to the injection procedure were rare. These included serious eye infection, detached retina, and cataract. Other uncommon serious side effects included inflammation inside the eye and increased eye pressure.
The most common eye-related side effects were red eye, eye pain, small specks in vision, the feeling that something is in your eye, and increased tears. The most common non–eye-related side effects were high blood pressure, nose and throat infection, and headache.
LUCENTIS is for prescription use only.
Individual results with LUCENTIS may vary.
Please see LUCENTIS full Prescribing Information.
